potassium-magnesium-aspartate has been researched along with Heart-Failure* in 4 studies
4 other study(ies) available for potassium-magnesium-aspartate and Heart-Failure
Article | Year |
---|---|
[Potentiated polarized liquid therapy and heart emergency].
Kalium and Magnesium ions are important cations in human body, both of them take part in many processes of metabolism in coordination. Injection of Kalii L-aspartatis and Magnesii L-aspartatis added to polarized liquid (GIK-Glucose, Insulin, Kalii Chlorid) might potentiate its effect and reduce carbon dioxide and ammonia in blood. 72 patients with various heart emergencies and other critical diseases were treated with potentiated polarized liquid (GIKL) with remarkable efficacy. A preliminary study on its clinical use and mechanism was carried out. Topics: Adult; Aged; Arrhythmias, Cardiac; Cardioplegic Solutions; Female; Glucose; Heart Failure; Humans; Insulin; Male; Middle Aged; Potassium; Potassium Magnesium Aspartate; Respiratory Insufficiency | 1992 |
[Correction of metabolic disorders of the myocardium in acute myocardial infarct as an important factor in preventing the development of circulatory insufficiency].
Topics: Animals; Aprotinin; Ascorbic Acid; Drug Therapy, Combination; Glutamates; Glutamic Acid; Heart Failure; Ibuprofen; Myocardial Infarction; Myocardium; Nandrolone; Nandrolone Decanoate; Nifedipine; Potassium Magnesium Aspartate; Propranolol; Rabbits; Sodium Oxybate; Vitamin E | 1985 |
[Treatment of acute left-ventricular insufficiency complicated by tachyarrhythmia under conditions of cardiological emergency service].
The article analyses 188 cases treated for acute left ventricular insufficiency (ALVI) in different forms of tachyarrhythmia. It was established that in patients with supraventricular paroxysmal tachycardia ALVI develops when the rate of cardiac contractions is 180 +/- 3/min on the average, whereas in patients with cardiac fibrillation it develops when the rate of contractions is 163 +/- 4/min. For successful treatment of ALVI of a tachyarrhythmic character it is necessary to restore the sinus rhythm or slow down the rhythm of cardiac contractions in patients with supraventricular paroxysmal tachycardia to 113 +/- 5/min on the average and in patients with cardiac fibrillation to 118 +/- 2/min. Isoptin and obsidan produce the highest decelerating effect. In half of the patients with tachyarrhythmia. ALVI was relieved by means of antiarrhythmic agents among which obsidan and isoptin proved most effective. Topics: Acute Disease; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Drug Therapy, Combination; Electric Countershock; Female; First Aid; Heart Failure; Humans; Male; Middle Aged; Potassium Magnesium Aspartate; Procainamide; Propranolol; Strophanthins; Verapamil | 1979 |
[Panangin treatment in cardiac insufficiency].
Topics: Aspartic Acid; Chronic Disease; Heart Failure; Humans; Injections, Intravenous; Potassium Magnesium Aspartate | 1977 |